Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2019 Jan;22(1):e25221.
doi: 10.1002/jia2.25221.

Dynamics in HIV-DNA levels over time in HIV controllers

Collaborators, Affiliations
Multicenter Study

Dynamics in HIV-DNA levels over time in HIV controllers

Véronique Avettand-Fenoel et al. J Int AIDS Soc. 2019 Jan.

Abstract

Introduction: HIV controllers (HIC) maintain viraemia at low levels without antiretroviral treatment and have small HIV reservoirs. Nevertheless, they are heterogeneous regarding their risk of infection progression. The study of reservoirs can help elucidate this control. This study aimed to explore the factors implicated in the pathogenesis of HIV infection that are potentially associated with HIV reservoirs and their dynamics in HIC.

Methods: Individuals living with HIV included in the ANRS-CODEX cohort with at least two HIV-DNA measurements between 2009 and 2016 were selected. The total HIV-DNA levels had been quantified prospectively from blood samples. Mixed-effect linear models estimated the HIV-DNA dynamics over time.

Results: The median (interquartile range (IQR)) HIV-DNA level was 1.5 (1.3 to 1.9) log copies/million peripheral blood mononuclear cells at inclusion (n = 202 individuals). These low levels showed heterogeneity among HIC. Lower levels were then associated with the protective HLA-B*27/B*57 alleles and/or lower HIV-RNA level at inclusion, negative hepatitis C virus serology, lower HIV-suppressive capacity of specific CD8 T cells and lower levels of immune activation and inflammation. Interestingly, mathematical modelling of the dynamics of HIV-DNA over time (840 measurements) showed that the number of infected cells decreased in 46% of HIC (follow-up: 47.6 months) and increased in 54% of HIC. A multivariate analysis indicated that HLA-B*27/B*57 alleles, a low level of HIV-RNA and a low level of HIV-DNA at inclusion were markers independently associated with this decrease.

Conclusions: These results offer new insights into the mechanisms of long-term control in HIC. In half of HIC, the decrease in HIV-DNA level could be linked to tighter viral control and progressive loss of infected cells. These findings allow the identification of HIC with a low risk of progression who may not need treatment.

Keywords: HIV controllers; HIV reservoir; dynamics; long-term follow-up; total HIV-DNA.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Model of the dynamics of the total HIVDNA levels, with 95% confidence intervals, in the blood of HIV controllers during a follow‐up period of more than six years, according to their HLA‐B*27 and/or B*57 status.
Slope of HIVDNA load for HIC with protective HLA‐B*27 and/or B*57 alleles: −0.023 log copies/million PBMC/year; for HIC without HLA‐B*27 and/or B*57 alleles: +0.038 log copies/million PBMC/year, p = 0.002. Solid lines indicate the estimated means and dashed lines indicate the 95% confidence intervals around means log 10 DNA copies/million over time. HIC, HIV controllers.
Figure 2
Figure 2. Model of the dynamics of the total HIVDNA levels, with 95% confidence intervals, in HIV controllers during a follow‐up period of more than six years, according to the levels of HIVRNA over time.
Slope of HIVDNA load for HIC who always had HIVRNA ≥1 log copies/mL during follow‐up: +0.060 log/year; for other HIC: −0.022 log/year; p < 0.0001. Solid lines indicate the estimated means and dashed lines indicate the 95% confidence intervals around means log 10 DNA copies/million over time. HIC, HIV controllers.

Comment in

References

    1. Lambotte O, Boufassa F, Madec Y, Nguyen A, Goujard C, Meyer L, et al. HIV controllers: a homogeneous group of HIV‐1‐infected patients with spontaneous control of viral replication. Clin Infect Dis. 2005;41(7):1053–6. - PubMed
    1. Noel N, Lerolle N, Lecuroux C, Goujard C, Venet A, Saez‐Cirion A, et al. Immunologic and virologic progression in HIV controllers: the role of viral “Blips” and immune activation in the ANRS CO21 CODEX study. PLoS ONE. 2015;10(7):e0131922. - PMC - PubMed
    1. Leon A, Perez I, Ruiz‐Mateos E, Benito JM, Leal M, Lopez‐Galindez C, et al. Rate and predictors of progression in elite and viremic HIV‐1 controllers. AIDS. 2016;30(8):1209–20. - PubMed
    1. Canoui E, Lecuroux C, Avettand‐Fenoel V, Gousset M, Rouzioux C, Saez‐Cirion A, et al. A subset of extreme human immunodeficiency virus (HIV) controllers is characterized by a small HIV blood reservoir and a weak T‐cell activation level. Open Forum Infect Dis 2017; 4:ofx064. - PMC - PubMed
    1. Autran B, Descours B, Avettand‐Fenoel V, Rouzioux C. Elite controllers as a model of functional cure. Curr Opin HIV AIDS. 2011;6(3):181–7. - PubMed

Publication types

MeSH terms